TIMM44 is a potential therapeutic target of human glioma.
Guo YZ, Chen G, Huang M, Wang Y, Liu YY, Jiang Q, Cao C, Liu F.
Guo YZ, et al. Among authors: liu yy, liu f.
Theranostics. 2022 Oct 31;12(17):7586-7602. doi: 10.7150/thno.78616. eCollection 2022.
Theranostics. 2022.
PMID: 36438483
Free PMC article.